Clinical Trials Browser

Phase 1 × IL32 protein, human × 90 days × Clear all

NCT02573896 2026-03-23

Immunotherapy of Relapsed Refractory Neuroblastoma With Expanded NK Cells

Phase 1 Active not recruiting

Neuroblastoma